You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0167 Low Levels of Infliximab at Early Stages Predict The Loss of Drug Levels and The Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0167 Low Levels of Infliximab at Early Stages Predict The Loss of Drug Levels and The Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis

Authors

Citation

Jurado T, Plasencia C, Martínez-Feito A, et al
FRI0167 Low Levels of Infliximab at Early Stages Predict The Loss of Drug Levels and The Clinical Response at One Year of Treatment in Patients with Rheumatoid Arthritis
Annals of the Rheumatic Diseases 2016;75:490.

Publication history

  • First published July 15, 2016.
Online issue publication 
July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions